141 related articles for article (PubMed ID: 18312479)
1. PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging.
Hennig BJ; Fry AE; Hirai K; Tahara H; Tamori A; Moller M; Hopkin J; Hill AV; Bodmer W; Beverley P; Tchilian E
Tissue Antigens; 2008 May; 71(5):458-63. PubMed ID: 18312479
[TBL] [Abstract][Full Text] [Related]
2. Geographical distribution and disease associations of the CD45 exon 6 138G variant.
Ward V; Hennig BJ; Hirai K; Tahara H; Tamori A; Dawes R; Saito M; Bangham C; Stephens H; Goldfeld AE; Kunachiwa W; Leetrakool N; Hopkin J; Dunstan S; Hill A; Bodmer W; Beverley PC; Tchilian EZ
Immunogenetics; 2006 Apr; 58(2-3):235-9. PubMed ID: 16538473
[TBL] [Abstract][Full Text] [Related]
3. Disease associations and altered immune function in CD45 138G variant carriers.
Boxall S; Stanton T; Hirai K; Ward V; Yasui T; Tahara H; Tamori A; Nishiguchi S; Shiomi S; Ishiko O; Inaba M; Nishizawa Y; Dawes R; Bodmer W; Beverley PC; Tchilian EZ
Hum Mol Genet; 2004 Oct; 13(20):2377-84. PubMed ID: 15333587
[TBL] [Abstract][Full Text] [Related]
4. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease.
Horst-Sikorska W; Ignaszak-Szczepaniak M; Marcinkowska M; Kaczmarek M; Stajgis M; Slomski R
Acta Biochim Pol; 2008; 55(2):371-80. PubMed ID: 18506225
[TBL] [Abstract][Full Text] [Related]
6. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
Dawes R; Hennig B; Irving W; Petrova S; Boxall S; Ward V; Wallace D; Macallan DC; Thursz M; Hill A; Bodmer W; Beverley PC; Tchilian EZ
J Med Genet; 2006 Aug; 43(8):678-84. PubMed ID: 16505159
[TBL] [Abstract][Full Text] [Related]
7. A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population.
Jennings CE; Owen CJ; Wilson V; Pearce SH
J Mol Endocrinol; 2005 Jun; 34(3):859-63. PubMed ID: 15956353
[TBL] [Abstract][Full Text] [Related]
8. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
9. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
Gu XJ; Cui B; Zhao ZF; Chen HY; Li XY; Wang S; Ning G; Zhao YJ
Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
11. Haplotype tagging efficiency in worldwide populations in CTLA4 gene.
RamÃrez-Soriano A; Lao O; Soldevila M; Calafell F; Bertranpetit J; Comas D
Genes Immun; 2005 Dec; 6(8):646-57. PubMed ID: 16034471
[TBL] [Abstract][Full Text] [Related]
12. CD45 exon 4 point mutation does not confer susceptibility to type 1 diabetes mellitus or Graves' disease.
Wood JP; Bieda K; Segni M; Herwig J; Krause M; Usadel KH; Badenhoop K
Eur J Immunogenet; 2002 Feb; 29(1):73-4. PubMed ID: 11841494
[TBL] [Abstract][Full Text] [Related]
13. CD45 (PTPRC) as a candidate gene in multiple sclerosis.
Vyshkina T; Leist TP; Shugart YY; Kalman B
Mult Scler; 2004 Dec; 10(6):614-7. PubMed ID: 15584483
[TBL] [Abstract][Full Text] [Related]
14. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease.
Hiromatsu Y; Mukai T; Kaku H; Miyake I; Ichimura M; Fukutani T; Nakayama H; Takata K; Imamura Y; Shoji S; Yamada K; Koda Y; Bednarczuk T
Diabet Med; 2006 Feb; 23(2):211-5. PubMed ID: 16433722
[TBL] [Abstract][Full Text] [Related]
15. Altered CD45 expression and disease.
Tchilian EZ; Beverley PC
Trends Immunol; 2006 Mar; 27(3):146-53. PubMed ID: 16423560
[TBL] [Abstract][Full Text] [Related]
16. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population.
Ban Y; Tozaki T; Taniyama M; Nakano Y; Ban Y; Ban Y; Hirano T
Thyroid; 2010 Aug; 20(8):893-9. PubMed ID: 20615141
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease.
Yan N; Meng S; Song RH; Qin Q; Wang X; Yao Q; Jiang Y; Jiang W; Shi L; Xu J; Zhang J
J Mol Endocrinol; 2015 Dec; 55(3):209-18. PubMed ID: 26373794
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
19. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients.
Cocco E; Murru MR; Melis C; Schirru L; Solla E; Lai M; Rolesu M; Marrosu MG
J Neurol; 2004 Sep; 251(9):1085-8. PubMed ID: 15372250
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population.
Szvetko AL; Jones A; Mackenzie J; Tajouri L; Csurhes PA; Greer JM; Pender MP; Griffiths LR
Brain Res; 2009 Feb; 1255():148-52. PubMed ID: 19111528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
